Medline Industries’ sales grew nearly 15% to $20.1 billion last year as the medtech manufacturer and distributor added more than 230 additional healthcare providers to its prime vendor partnerships.
The new relationships, announced today, were worth nearly $2 billion in annual, incremental sales of medical supplies and services spanning the care continuum. The new health provider partnerships included Northwestern Medicine in Illinois, Rochester Regional Health in New York, Kelsey-Seybold Clinic in Texas, Windsor Lane Health Care in Ohio, Ochsner Health in Louisiana, and Golden LivingCenters in Indiana.
“Throughout 2021, the Medline team remained laser-focused on supporting our customers through another challenging year and strengthening the resiliency of the healthcare supply chain,” said Doug Golwas, EVP of acute care sales for Medline.
“Heading into 2022, that commitment remains as we continue to partner with our customers and together identify new strategies to enhance operational and clinical efficiencies,” Golwas said in a news release.
The results could boost privately held Medline even higher in the rankings of Medical Design & Outsourcing‘s next Big 100 report, which ranks the largest medical device companies in the world by revenue. (Expect the new Big 100 to go live in the late summer.)
With $17.5 billion in revenue in 2020, Medline was No. 6 in last year’s report.
Northfield, Illinois–based Medline is taking steps to grow its reach even more in 2022. The company is spending $1.5 billion on new distribution centers, manufacturing capabilities and IT upgrades. The company opened five newly constructed distribution centers in 2021 and plans to complete two more in 2022.
Blackstone, Carlyle and Hellman & Friedman made a multi-billion-dollar investment in Medline last year, with the Mills family remaining as the largest single shareholder.